View in EDS

1833-P: A Novel Genetic Modified and Pegylated FGF21 Analog for the Treatment of Nonalcoholic Steatohepatitis in Nonhuman Primates.

Saved in:
Bibliographic Details
Title: 1833-P: A Novel Genetic Modified and Pegylated FGF21 Analog for the Treatment of Nonalcoholic Steatohepatitis in Nonhuman Primates.
Authors: CUI, AOYUAN1 (AUTHOR), LI, JIAN1 (AUTHOR), JI, SHAOHUI1 (AUTHOR), MA, FENGGUANG1 (AUTHOR), WANG, GENBEI1 (AUTHOR), XUE, YAQIAN1 (AUTHOR), LIU, ZHENGSHUAI1 (AUTHOR), MA, XIAOHUI1 (AUTHOR), LI, YU1 (AUTHOR)
Source: Diabetes. 2020 Supplement, Vol. 69, pN.PAG-N.PAG. 1p.
Database: Academic Search Ultimate
Description
ISSN:00121797
DOI:10.2337/db20-1833-P